3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Withdrawn
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Lymphoma
3
Recurrence
2
Lymphoma, T-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Adenocarcinoma
1
Interventions
Gemcitabine
3
Nivolumab
2
temoporfin
1
spartalizumab
1
polysaccharide-K
1
pembrolizumab
1
nimotuzumab
1
devimistat
1
dalotuzumab
1
bemarituzumab
1
belinostat
1
Transurethral Resection of Prostate
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Radiofrequency Ablation
1
Oxaliplatin
1
Morphine
1
Methadone
1
Leucovorin
1
Ipilimumab
1
Interviews as Topic
1
Injections
1
Immunotherapy
1
Heavy Ion Radiotherapy
1
Fluorouracil
1
Erlotinib Hydrochloride
1
Docetaxel
1
Cryosurgery
1
Cisplatin
1
Brachytherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Adenocarcinoma
×
belinostat
×
Clear all
NCT04315155
2020-10-28
BENEFIT
University of Utah
Phase 1
Withdrawn